Lehrstuhl für Geburtshilfe und Frauenheilkunde

A Hybrid Type III Effectiveness-Implementation Trial to Optimize Medication Safety With Oral Antitumor Therapy in Real-World: The AMBORA Competence and Consultation Center. (2024) Cuba L, Dürr P, Geßner K, Häcker B, Fietkau R, Siebler J, Pavel ME, et al. Journal article Trial of labor after caesarean section in low risk pregnancies: is it risky? (2024) Kehl S, Düster H, Weiss C, Bader S, Schneider M, Beckmann M, Dammer U, Pretscher J Journal article Quality assurance using quality indicators for prevention and early detection of cervical cancer in certified gynaecological dysplasia units and consultancies (2024) Steinkasserer L, Wesselmann S, Quaas J, Beckmann M, Dannecker C, Hachenberg J, Jentschke M, Hillemanns P Journal article BRCA-mutated breast cancer: the unmet need, challenges and therapeutic benefits of genetic testing (2024) Arun B, Couch FJ, Abraham J, Tung N, Fasching P Journal article, Review article Co-observation of germline pathogenic variants in breast cancer predisposition genes: Results from analysis of the BRIDGES sequencing dataset (2024) Davidson AL, Michailidou K, Parsons MT, Fortuno C, Bolla MK, Wang Q, Dennis J, et al. Journal article Can Chat-GPT read and understand guidelines? An example using the S2k guideline intrauterine growth restriction of the German Society for Gynecology and Obstetrics (2024) Psilopatis I, Bader S, Krückel A, Kehl S, Beckmann M, Emons J Journal article Update Breast Cancer 2024 Part 1 - Expert Opinion on Advanced Breast Cancer (2024) Würstlein R, Kolberg HC, Hartkopf AD, Fehm TN, Welslau M, Schütz F, Fasching P, et al. Journal article Correlation of RANK and RANKL with mammographic density in primary breast cancer patients (2024) Wunderle M, Heindl F, Behrens A, Häberle L, Hack C, Heusinger K, Hübner H, et al. Journal article Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions (2024) Dareng EO, Coetzee SG, Tyrer JP, Peng PC, Rosenow W, Chen S, Davis BD, et al. Journal article Quality-Assured Analysis of PIK3CA Mutations in Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer Tissue: A Story About the Need for Proficiency Testing for High-Quality Molecular Biomarker Reporting in Precision Medicine (2024) Schmidt C, Stöhr R, Dimitrova L, Beckmann M, Rübner M, Fasching P, Denkert C, et al. Journal article